Condition

Metastatic Hormone Naive Prostate Cancer (1)

Metastatic Prostate Cancer (1)

Prostate Cancer (1)

Prostatic Neoplasms (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Not yet recruiting (1)

Phase

phase 2 (2)

phase 3 (1)

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC (1)

Janssen Pharmaceutical K.K. (1)

MedSIR (1)

Peter MacCallum Cancer Centre, Australia (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (3)

Observational [Patient Registry] (1)

mHNPC

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

Recruiting

Metastatic Prostate Cancer

Badalona, Spain
+8 more

Jan 18, 2023

Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)

Active, not recruiting

Prostatic Neoplasms

Androgen-deprivation Therapy (ADT)
+6 more

Akita, Japan
+76 more

Jan 19, 2023

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting

Metastatic Hormone Naive Prostate Cancer

Sydney, New South Wales, Australia
+4 more

Nov 4, 2022

Prostate Cancer Trial (iMAB, cMAB)

Not yet recruiting

Prostate Cancer

iMAB
cMAB

(no location specified)

Jul 26, 2023